To the full analysis
Amplifon stock: growth
AMP.MIAmplifon reported $2.65B in revenue for fiscal 2025, down 0.6% on the prior year, up 9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7.4%
per year from 2006 to 2025, per share 6.8%
Earnings (Annual rate)
2.9%
per year from 2006 to 2025, per share 2.8%
Free cash flow (Annual rate)
11.9%
per year from 2006 to 2025, per share 11.3%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 9.0% | 8.8% | 7.4% |
| Revenue per share | 9.4% | 8.7% | 6.8% |
| Earnings | −2.0% | 6.9% | 2.9% |
| Earnings per share | −1.4% | 7.2% | 2.8% |
| Free cash flow | −2.2% | 14.3% | 11.9% |
| Free cash flow per share | −1.8% | 14.2% | 11.3% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $679.4M | $58.43M | $38.55M |
| 2007 | $740.14M | $17.36M | $49.43M |
| 2008 | $710.78M | −$15.82M | $67.36M |
| 2009 | $728.06M | $32.33M | $56.28M |
| 2010 | $784.64M | $33.89M | $63.1M |
| 2011 | $916.89M | $47.35M | $44.93M |
| 2012 | $938.13M | $47.85M | $71.85M |
| 2013 | $918.21M | $14.24M | $59.2M |
| 2014 | $987.24M | $51.5M | $80.79M |
| 2015 | $1.15B | $51.86M | $86.43M |
| 2016 | $1.26B | $70.5M | $89.95M |
| 2017 | $1.4B | $111.45M | $107.24M |
| 2018 | $1.51B | $111.3M | $114.05M |
| 2019 | $1.92B | $120.41M | $252.93M |
| 2020 | $1.72B | $111.92M | $366.37M |
| 2021 | $2.16B | $174.84M | $386.69M |
| 2022 | $2.35B | $197.82M | $380.07M |
| 2023 | $2.5B | $171.91M | $301.28M |
| 2024 | $2.67B | $161.09M | $405.77M |
| 2025 | $2.65B | $101.21M | $328.39M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak since 10 Nov 2026, previously Neutral
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.